GEMS Equity Strategy
Country Model Update: Going Underweight Brazil
December 18, 2007

By Jonathan Garner

Our quantitative country model leads us to make the following changes to our country allocation:

Downgrades: Brazil to underweight from equal weight; South Africa to UW from EW; Poland to EW from OW; Turkey to EW from OW.

Upgrades: Chile to OW from EW; Hungary to OW from EW; Egypt to EW from UW; Philippines to EW from UW.

The model's ranking of Brazil has fallen from #12 to #17 this month due mainly to deteriorating relative valuation scores and rising currency risk (the latter feature shared with both South Africa and Turkey).

In our view the “virtuous circle” of exchange rate appreciation, commodity price strength, sovereign risk premium reduction, and equity valuation convergence has now run its course in Brazil. Forward P/E has essentially reached parity with the rest of EM and is also now well above the 5-year historically observed fit level to the sovereign spread. In absolute terms it has only been higher 10% of the time in the last 10 years.

Brazil's real effective exchange rate has doubled since the nadir of 2001/02. Our Latam economics team's expectation of a slower pace of interest rate declines, worse than consensus trade outlook, and downside risk to the currency implies a more difficult environment for the domestic demand sectors (banks, telecoms and retailers) in the Brazilian equity market next year.

It is time to be more selective, and we would choose to retain exposure to oils and mining. For Latam managers, we would recommend switching domestic demand exposure to Chile, while for BRIC managers we prefer exposure in Russia.

Currencies
A Retrospective On 2007: Another Weak Dollar Year
December 18, 2007

By Stephen L. Jen

2007 has been marked by powerful macro trends and cross-currents. Many of the themes that dominated 2007 will likely be at least as relevant in 2008.

Our market calls for the past year: We were correct on the direction of the dollar, but we significantly underestimated its sell-off. While we anticipated this being another year marked by a cyclical dollar descent, with the US economy being singled out as the only soft spot in the world, we attached a remote possibility to EUR/USD getting anywhere near 1.50. This was because we underestimated the power of central bank diversification and how quickly the world would lose confidence in the dollar. We were consistently positive on EM currencies in general and the AXJ currencies in particular, which was a good call.

Some of our qualitative calls are noteworthy. We were very positive on the global economy, and consistently argued that risky assets (mainly equities) would rise enthusiastically but fall grudgingly. We were among the first to highlight the importance of sovereign wealth funds (SWFs). We also placed considerable emphasis on the declining home bias in many EM economies.

Key lessons for 2008: We identify four key lessons that matter for the currency markets for 2008. (1) This is more than a subprime crisis. It will take time for banks to sort out their balance sheet problems. (2) Central banks are potent, and the Fed's willingness to deal with the liquidity issue should not be questioned. However, whether the interbank money market dislocations can be fully resolved will be a function of how banks' confidence may be altered by the Fed's action. (3) The fruits of globalisation have been exceedingly evident this year. Not long ago, EM decoupling from the US was unthinkable. (4) The rise of SWFs is genuine, and we are at the beginning of a long-term process.

US Equity Strategy
American Gangster - Inflation Risks Compound Earnings Drag
December 18, 2007

By Abhijit Chakrabortti

Last week's elevated inflation readings point to further near-term downside risk for the S&P 500 in general and financials in particular.

Those hoping that rapid and aggressive global monetary easing will offset growth and earnings deterioration may be forced to rethink assumptions regarding the timing and pace of policy response.

We are not suggesting that inflation readings will prevent the Fed from responding to growth concerns. Our base case remains for Fed funds to be 3.5% by mid-2008. However, the deterioration in asset quality, growth data and earnings estimates may be more rapid than the Fed's response.

In other words, the recent disappointment at a 25 bp rather than 50 bp cut that occurred in early December may well be repeated as the Fed takes an even more “measured” pace to rate cuts (potentially skipping cuts at some meetings next year). Similarly, ongoing elevated inflation readings in the Eurozone may reinforce the ECB's resolve to stay put, placing at risk hopes of concerted global easing.

For US financials, these inflation readings are especially negative as they potentially reduce the prospect of more rapid monetary easing, which is an almost consensus expectation, and, in our view, financials' strongest support.

At the current headline level (4.3% YoY), inflation is now running 1% above the long-term average. Based on our valuation model, this has the effect of reducing the fair value P/E by 1 point. Assuming flat reported earnings growth in 2008 (and this may well prove optimistic), this points to downside for the S&P 500 at 1350 ($83 reported earnings and 16.3x P/E). Clearly, not an outcome widely anticipated.

Japan Equity Strategy
Want To Be a Japan Equity Strategist?
December 18, 2007

By Naoki Kamiyama

China a potential buyer of Japanese stocks: The China Investment Corporation (CIC) is a potential buyer of almost Y1 trillion in Japanese stock. If it is able to hire the right investment personnel, such purchasing could start in six months to a year. Initially, we think the CIC will likely purchase broadly, in index baskets rather than in certain sectors.

Japanese equity strategists in Beijing: The November 26 Nikkei Shimbun (evening edition) reported that the Chinese government in effect will begin investing assets in Japanese stocks, based on recent recruitment ads for strategists at the CIC website. On November 29, the CIC partially outlined its current investment strategy. You, too, could become a Japan equity strategist, in Beijing.

Long-term investment strategy too: While the CIC will seek risk dispersal for falling US dollar asset values, its investments will also be strategically aimed at yen-denominated assets, so as to acquire the right assets and technology for sustainable growth of the Chinese economy. This could take 3-5 years.

Asia/Pacific Equity Strategy
Avoid the Highly Leveraged
December 18, 2007

By Malcolm Wood

While the current US-led credit market turmoil should theoretically have limited impact on the Asian corporate sector, the blowout in credit spreads could easily lead highly leveraged stocks to underperform. With high dependence on bond funding and an elevated bank loan-deposit ratio, Korea appears vulnerable, as do select stocks elsewhere.

Despite sharp increases in credit spreads, Asia's highly leveraged stocks have not yet materially underperformed.

The AxJ iTraxx Index Has Blown Out By 100 bp. The iTraxx index for Asia ex-Japan has risen sharply since July, tracking the rise of global credit spreads. This has occurred despite Asia's strong fundamentals. First, Asian balance sheet leverage is at a record low 33.7%, about half the level of a decade ago. Second, bond issues constitute a relatively small part of Asian corporate finance, with total private-sector bond issuance reaching US$49 billion in 2006 (vs. loan growth of US$842 bn and equity issuance of US$156 bn). Third, the banking system is very liquid, with the loan-to-deposit ratio at a near-record low 73%.

Korea appears vulnerable. While Korean corporates have deleveraged substantially over the past decade (from 335% in 1997 to 37% in 2006), the relatively high dependence on bond funding (US$39 bn YTD vs. equity issuance of US$6 bn) and an elevated loan to deposit ratio (136%) appear to expose Korea companies to current credit market turmoil. Indeed, the Bank of Korea injected liquidity via the bond market late last month to curb surging short rates and alleviate a funding squeeze.

Avoid High Leveraged Companies. During bull markets, highly geared companies tend to outperform. However, with current credit market turmoil, highly geared stocks may suffer from funding constraints, limiting their growth potential and reversing their outperformance. For example, select highly leveraged Chinese property developers have corrected sharply on the back of failed bond issues.

Asia/Pacific Economics
Limited Recoupling Ahead
December 18, 2007

By Chetan Ahya

External environment likely to deteriorate in 2008: The risk of credit problems attacking the heart of US growth - household consumption - has increased significantly. Morgan Stanley's US Economics team now expects a mild recession in 2008.

Limited recoupling in 2008: We estimate that AXJ growth will slow significantly, to about 7% in 2H08 from 9% YoY in 3Q07, but this would be significantly less severe than in the 2001 recession.

AXJ better placed to face US recession: The macro balance sheet is much less vulnerable to external shocks in the current cycle than was the case in 2001. Domestic demand dynamics are also much better in the current cycle.

Downside risk: Significant turbulence in the US equity markets could spread to Asian financial markets.

Australia Equity Strategy
2008 Outlook: Neutral Equities; Mild US Recession
December 18, 2007

By Gerard Minack, Toby Walker, Antony Conte

We are neutral Australian equities and think risks are to the downside. We think earnings growth will remain positive, but a US recession could worsen what is already a declining trend. We think 2009 consensus earnings growth of 11.7% is more at risk (particularly the 17.6% forecast for metals & mining). Importantly, domestic multiples remain at stretched levels, and we think a multiple de-rating is required to price in what are now substantial global risks. Finally, correlation to US markets means we would not avoid the ramifications of a US bear market or a fall in investor risk appetite.

Recession in the US and a global growth slowdown: Our US economics team expects a mild US recession in 2008. We are already seeing an earnings recession in the US, and our European team expects negative earnings growth as well. Whilst EM and Asia/Pacific growth should remain positive, it may slow due to a combined US and EU decline.

Our index target: Our S&P/ASX 200 target of 6,693 is a probability weighted target of our Bull Case (7,639, 20% probability), Base Case (6,761, 50% probability), and Bear Case (5,949, 30% probability). This implies that the Australian equity market ends the year broadly flat.

A defensive strategy: We seek non-cyclical, defensive sectors at this stage. Our sector preferences are banks, healthcare, food & beverages, infrastructure, and utilities. We like dividend yield, and also think stable growth should continue to outperform contrarian value as conditions deteriorate. Critical to this will be timing any recovery, for value and cyclical stocks should then sharply outperform. See our full note for ten stocks that our analysts recommend and meet our defensive criteria.

India Equity Strategy
The Year That Was
December 18, 2007

By Ridham Desai

2007 was the fourth successive bumper year for market intermediaries, i.e., brokerages, mutual funds and investment banks and market participants. Equity investors had a superb year, especially in the second half, with returns improving down the cap curve in the last quarter and volatility rising only marginally.

Trading volumes jumped a whopping 65% y/y and the dollar value of trading has more than quadrupled in four years, thanks in part to the big increase in share prices. Institutional trading volumes rose more than 80% y/y, with their share in total trading rising by 3 pp to 26%. Equity issuance rose 30% in 2007 and M&A volumes almost doubled y/y. Fixed income funds experienced a big surge in flows although equity flows fell about 25%. Assets under management reached record levels across the board and have quadrupled in four years.

Indian equities produced another stellar year with absolute and relative gains. India is currently on course to finish the year as the third-best EM. Mid- and small-caps regained their edge over large caps, though the bulk of this has happened in the closing stages of the year. India's relative gains versus EM have also been concentrated in the last quarter. Nine out of the 10 MSCI sectors produced positive returns. The best in class were utilities, energy and industrials, whereas the worst sectors were technology, discretionary and healthcare.

Net earnings for MS coverage universe was up 38%, a distinct improvement from 2006. Earnings were helped by margin expansion and strong net financial income. Earnings revisions stayed strong as in the previous three years, with the F2009 consensus EPS estimate for the BSE Sensex constituents rising about 10% from the start of 2007.

The bulk of India's outperformance over EM was explained by an increase in the relative multiple for India. The relative multiple was up 20% through the year. The biggest sector level re-rating took place in telecoms, utilities and energy. Technology, healthcare and consumer discretionary suffered de-rating.

Global Market Trading Strategy
Equities React from Relevant Resistance
December 18, 2007

By Paul Ruddleston

Global equity markets have climbed a long way from their 2002/03 lows, consistently stepping up from the 'bigger picture' support areas according to our analysis. We believe that medium-term upside objectives in the regionally representative equity indices - namely S&P 500 at 1700, 1725 (NDX 2400, 2600 etc); TWSE 10,600, 11,300; Nikkei 225 at 20,300; SX5E at 4700, 5300 - remain well within the realms of reality. However, although the bigger-picture uptrend remains intact, it is not in force at the moment according to our analysis.

The Wall of Worry with which equity markets have had to contend for most of their upward journey continues to hold firm. Fundamental concerns about US growth prospects, which have been consistently reflected in bond, dollar and sectoral weaknesses e.g., Banks, Housebuilders) since the middle of 2006, can easily spill over into fears of a broader, more global growth shortfall. More recently and specifically, given the importance of liquidity in any market equation, the fact that short-term US bank deposit rates have reached their widest differential over US Government Treasury Bill rates since 1987 (and in ratio terms are far wider) is indicative of the marked illiquidity threat to markets.

Focusing on the shorter-term situation, we note that at the end of November, the S&P 500 (our global equity market proxy) rallied powerfully from the area we defined as support for a "surprise" rally around 1400. However, since then prices have reached and reacted from the nearest relevant resistance region at 1520/30 (in conjunction with the Nasdaq 100 falling from the equivalent barrier around 2150), which we defined as the "risk reduction" zone. Also, we observe that both the Russell 2000 (a reasonable guide to both liquidity and US domestic growth conditions) and the Nasdaq 100 (our global technology/psychology indicator) continue to underperform the broader market. As long as the aforementioned barrier (SPX at 1520/30, etc.) holds firm (or we see a combination across the asset classes suggestive of stability), we will remain in a heightened risk environment and therefore continue to be "suspicious of strength".

We realise that in the current heightened risk environment, we may well witness another attempt to pull the S&P 500 through the psychological support in the 1400 area all the way down towards the 1310/00 area (equivalent to Nasdaq 100 at 1800/1780, Russell 2000 at 650, Eurostoxx 50 at 3800/3750, Nikkei 225 at 13,500/400, etc.) before the uptrend can continue.

---

Analyst Certification
The following analysts hereby certify that their views about the companies and their securities discussed in this report are accurately expressed and that they have not received and will not receive direct or indirect compensation in exchange for expressing specific recommendations or views in this report: Jonathan Garner, Abhijit Chakrabortti, Naoki Kamiyama, Malcolm Wood, Ridham Desai, Paul Ruddleston.

Global Research Conflict Management Policy
This research has been published in accordance with our conflict management policy, which is available at www.morganstanley.com/institutional/research/conflictpolicies.

Important US Regulatory Disclosures on Subject Companies
The information and opinions in this report were prepared by Morgan Stanley & Co. International plc and its affiliates (collectively, "Morgan Stanley"). Certain disclosures listed below are also for compliance with applicable regulations in non-US jurisdictions.

The research analysts, strategists, or research associates principally responsible for the preparation of this research report have received compensation based upon various factors, including quality of research, investor client feedback, stock picking, competitive factors, firm revenues and overall investment banking revenues.

STOCK RATINGS
Different securities firms use a variety of rating terms as well as different rating systems to describe their recommendations. For example, Morgan Stanley uses a relative rating system including terms such as Overweight, Equal-weight or Underweight (see definitions below). A rating system using terms such as buy, hold and sell is not equivalent to our rating system. Investors should carefully read the definitions of all ratings used in Morgan Stanley Research. In addition, since Morgan Stanley Research contains more complete information concerning the analyst's views, investors should carefully read Morgan Stanley Research, in its entirety, and not infer the contents from the rating alone. In any case, ratings (or research) should not be used or relied upon as investment advice. An investor's decision to buy or sell a stock should depend on individual circumstances (such as the investor's existing holdings) and other considerations.

Global Stock Ratings Distribution
(as of November 30, 2007)
For disclosure purposes only (in accordance with NASD and NYSE requirements), we include the category headings of Buy, Hold, and Sell alongside our ratings of Overweight, Equal-weight and Underweight. Morgan Stanley does not assign ratings of Buy, Hold or Sell to the stocks we cover. Overweight, Equal-weight, and Underweight are not the equivalent of buy, hold, and sell but represent recommended relative weightings (see definitions below). To satisfy regulatory requirements, we correspond Overweight, our most positive stock rating, with a buy recommendation; we correspond Equal-weight and Underweight to hold and sell recommendations, respectively.

Data include common stock and ADRs currently assigned ratings. An investor's decision to buy or sell a stock should depend on individual circumstances (such as the investor's existing holdings) and other considerations. Investment Banking Clients are companies from whom Morgan Stanley or an affiliate received investment banking compensation in the last 12 months.

Analyst Stock Ratings
Overweight (O). The stock's total return is expected to exceed the average total return of the analyst's industry (or industry team's) coverage universe, on a risk-adjusted basis, over the next 12-18 months.
Equal-weight (E). The stock's total return is expected to be in line with the average total return of the analyst's industry (or industry team's) coverage universe, on a risk-adjusted basis, over the next 12-18 months.
Underweight (U). The stock's total return is expected to be below the average total return of the analyst's industry (or industry team's) coverage universe, on a risk-adjusted basis, over the next 12-18 months.
More volatile (V). We estimate that this stock has more than a 25% chance of a price move (up or down) of more than 25% in a month, based on a quantitative assessment of historical data, or in the analyst's view, it is likely to become materially more volatile over the next 1-12 months compared with the past three years. Stocks with less than one year of trading history are automatically rated as more volatile (unless otherwise noted). We note that securities that we do not currently consider "more volatile" can still perform in that manner.

Unless otherwise specified, the time frame for price targets included in this report is 12 to 18 months.

Analyst Industry Views
Attractive (A): The analyst expects the performance of his or her industry coverage universe over the next 12-18 months to be attractive vs. the relevant broad market benchmark, as indicated below.
In-Line (I): The analyst expects the performance of his or her industry coverage universe over the next 12-18 months to be in line with the relevant broad market benchmark, as indicated below.
Cautious (C): The analyst views the performance of his or her industry coverage universe over the next 12-18 months with caution vs. the relevant broad market benchmark, as indicated below.

Benchmarks for each region are as follows: North America - S&P 500; Latin America - relevant MSCI country index or MSCI Latin America Index; Europe - MSCI Europe; Japan - TOPIX; Asia - relevant MSCI country index.

Stock price charts and rating histories for companies discussed in this report are available at  www.morganstanley.com/companycharts or from your local investment representative. You may also request this information by writing to Morgan Stanley at 1585 Broadway, (Attention: Equity Research Management), New York, NY, 10036 USA.

---

Other Important Disclosures

Morgan Stanley produces a research product called a "Trade Idea." Views contained in a "Trade Idea" on a particular stock may be contrary to the recommendations or views expressed in this or other research on the same stock. This may be the result of differing time horizons, methodologies, market events, or other factors. For all research available on a particular stock, please contact your sales representative or go to Client Link at www.morganstanley.com.

For a discussion, if applicable, of the valuation methods used to determine the price targets included in this summary and the risks related to achieving these targets, please refer to the latest relevant published research on these stocks.

This report does not provide individually tailored investment advice. It has been prepared without regard to the individual financial circumstances and objectives of persons who receive it. The securities discussed in this report may not be suitable for all investors. Morgan Stanley recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. The appropriateness of a particular investment or strategy will depend on an investor's individual circumstances and objectives. The securities, instruments, or strategies discussed in this report may not be suitable for all investors, and certain investors may not be eligible to purchase or participate in some or all of them.

This report is not an offer to buy or sell or the solicitation of an offer to buy or sell any security or to participate in any particular trading strategy. The "Important US Regulatory Disclosures on Subject Companies" section lists all companies mentioned in this report where Morgan Stanley owns 1% or more of a of common securities of the companies. For all other companies mentioned in this report, Morgan Stanley may have an investment of less than 1% in securities or derivatives of securities of companies mentioned in this report, and may trade them in ways different from those discussed in this report. Employees of Morgan Stanley not involved in the preparation of this report may have investments in securities or derivatives of securities of companies mentioned in this report, and may trade them in ways different from those discussed in this report. Derivatives may be issued by Morgan Stanley or associated persons.

Morgan Stanley and its affiliate companies do business that relates to companies covered in its research reports, including market making and specialized trading, risk arbitrage and other proprietary trading, fund management, commercial banking, extension of credit, investment services and investment banking. Morgan Stanley sells to and buys from customers the securities/instruments of companies covered in its research reports on a principal basis.

With the exception of information regarding Morgan Stanley, reports prepared by Morgan Stanley research personnel are based on public information. Morgan Stanley makes every effort to use reliable, comprehensive information, but we make no representation that it is accurate or complete. We have no obligation to tell you when opinions or information in this report change apart from when we intend to discontinue research coverage of a subject company. Facts and views presented in this report have not been reviewed by, and may not reflect information known to, professionals in other Morgan Stanley business areas, including investment banking personnel.

Morgan Stanley research personnel conduct site visits from time to time but are prohibited from accepting payment or reimbursement by the company of travel expenses for such visits.

The value of and income from your investments may vary because of changes in interest rates or foreign exchange rates, securities prices or market indexes, operational or financial conditions of companies or other factors. There may be time limitations on the exercise of options or other rights in your securities transactions. Past performance is not necessarily a guide to future performance. Estimates of future performance are based on assumptions that may not be realized. Unless otherwise stated, the cover page provides the closing price on the primary exchange for the subject company's securities.

To our readers in Taiwan: Information on securities that trade in Taiwan is distributed by Morgan Stanley Taiwan Limited ("MSTL"). Such information is for your reference only. The reader should independently evaluate the investment risks and is solely responsible for their investment decisions. This publication may not be distributed to the public media or quoted or used by the public media without the express written consent of Morgan Stanley. Information on securities that do not trade in Taiwan is for informational purposes only and is not to be construed as a recommendation or a solicitation to trade in such securities. MSTL may not execute transactions for clients in these securities.

To our readers in Hong Kong: Information is distributed in Hong Kong by and on behalf of, and is attributable to, Morgan Stanley Asia Limited as part of its regulated activities in Hong Kong. If you have any queries concerning this publication, please contact our Hong Kong sales representatives.

This publication is disseminated in Japan by Morgan Stanley Japan Securities Co., Ltd.; in Hong Kong by Morgan Stanley Asia Limited (which accepts responsibility for its contents); in Singapore by Morgan Stanley Asia (Singapore) Pte. (Registration number 199206298Z) and/or Morgan Stanley Asia (Singapore) Securities Pte Ltd (Registration number 200008434H), regulated by the Monetary Authority of Singapore, which accepts responsibility for its contents; in Australia by Morgan Stanley Australia Limited A.B.N. 67 003 734 576, holder of Australian financial services licence No. 233742, which accepts responsibility for its contents; in Korea by Morgan Stanley & Co International plc, Seoul Branch; in India by Morgan Stanley India Company Private Limited; in Canada by Morgan Stanley Canada Limited, which has approved of, and has agreed to take responsibility for, the contents of this publication in Canada; in Germany by Morgan Stanley Bank AG, Frankfurt am Main, regulated by Bundesanstalt fuer Finanzdienstleistungsaufsicht (BaFin); in Spain by Morgan Stanley, S.V., S.A., a Morgan Stanley group company, which is supervised by the Spanish Securities Markets Commission (CNMV) and states that this document has been written and distributed in accordance with the rules of conduct applicable to financial research as established under Spanish regulations; in the United States by Morgan Stanley & Co. Incorporated, which accepts responsibility for its contents. Morgan Stanley & Co. International plc, authorized and regulated by Financial Services Authority, disseminates in the UK research that it has prepared, and approves solely for the purposes of section 21 of the Financial Services and Markets Act 2000, research which has been prepared by any of its affiliates. Private U.K. investors should obtain the advice of their Morgan Stanley & Co. International plc representative about the investments concerned. In Australia, this report, and any access to it, is intended only for "wholesale clients" within the meaning of the Australian Corporations Act.

The trademarks and service marks contained herein are the property of their respective owners. Third-party data providers make no warranties or representations of any kind relating to the accuracy, completeness, or timeliness of the data they provide and shall not have liability for any damages of any kind relating to such data. The Global Industry Classification Standard ("GICS") was developed by and is the exclusive property of MSCI and S&P.

This report or any portion hereof may not be reprinted, sold or redistributed without the written consent of Morgan Stanley.

Morgan Stanley research is disseminated and available primarily electronically, and, in some cases, in printed form.

Additional information on recommended securities is available on request.